Skip to content

News from the British HIV Association Fifth Annual Meeting

Atlantic study shows PI-sparing combos match indinavir after 48 weeks

Adefovir rejected for US license

40% of French combo patients have detectable viral load

Efavirenz side effects become long-term for over one in three

Virgin Islands conference summaries

UK joins new study on how to treat HIV in children: exclusive interview with Dr Gareth Tudor-Williams.

First human study of follow-on fusion inhibitor

Bill Gates hints at billions of dollars for HIV vaccine